Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Inesa Thomsen"'
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 10, Iss 1 (2017)
Introduction The UK Pharmaceutical Industry is arguably one of the most important industries to consider in the negotiations following the Brexit vote. Providing tens of thousands of jobs and billions in tax revenue and research investment, the impor
Externí odkaz:
https://doaj.org/article/2ba3c33f81bf44919ff26ff0dcfd6304
Autor:
Natalia Kunowska, Anne-Marie Moody, Mohammad M. Karimi, Roshni de Souza, Chad Whilding, Alexis R. Barr, Greg Crawford, Pierangela Sabbattini, Niall Dillon, Inesa Thomsen, Yi-Fang Wang, Jessica Strid, Sanjay Khadayate
Publikováno v:
The Journal of Immunology Author Choice
Key Points RUNX1 reduces cell cycle and immediate early gene expression in naive B cells.BCR stimulation triggers a switch from RUNX1 to RUNX3 binding at cell cycle genes.Notch signaling is downregulated by RUNX1 in follicular B cells.
RUNX1 is
RUNX1 is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc02fb450eada0284f0beea04fedff25
http://hdl.handle.net/10044/1/93244
http://hdl.handle.net/10044/1/93244
Autor:
Greg Crawford, Pierangela Sabbattini, Mohammad M. Karimi, Sanjay Khadayate, Natalia Kunowska, Roshni de Souza, Anne-Marie Moody, Yi-Fang Wang, Jessica Strid, Alexis R. Barr, Inesa Thomsen, Niall Dillon
RUNX1 is a transcription factor that plays key roles in haematopoietic development and in adult haematopoiesis and lymphopoiesis. Here we report that RUNX1 is also involved in controlling the dynamics of cell cycle entry of naïve resting B cells in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50357456b500cef83f8b309c69bb9c7f
https://doi.org/10.1101/2020.12.01.406744
https://doi.org/10.1101/2020.12.01.406744
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 10, Iss 1, Pp 1-12 (2017)
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice
Introduction The UK Pharmaceutical Industry is arguably one of the most important industries to consider in the negotiations following the Brexit vote. Providing tens of thousands of jobs and billions in tax revenue and research investment, the impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dedfa35ed86a76714724634b3c6e5e6
https://doi.org/10.1186/s40545-017-0120-z
https://doi.org/10.1186/s40545-017-0120-z